The global advanced empty capsules market is anticipated to generate revenues of US$ 905.6 million in 2023. Demand for advanced empty capsules is projected to develop at a CAGR of 7.4% and reach US$ 1,856.1 million by 2033. The market is experiencing significant growth due to several market-specific factors:
| Attribute | Details |
|---|---|
| Advanced Empty Capsule Market CAGR (2023 to 2033) | 7.4% |
| Advanced Empty Capsule Market Size (2023) | US$ 905.6 million |
| Advanced Empty Capsule Market Size (2033) | US$ 1,856.1 million |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Technological advancements have significantly impacted the advanced empty capsules sector. Introducing new technologies, such as the fusion of capsule parts and seals, has transformed the traditional use of hard gelatin capsules.
In health and nutritional applications, lipid-based formulations have been adopted to enhance bioavailability and mask taste and odor. Additionally, novel technologies enable the efficient filling of liquids and semi-solids into empty capsules, benefiting pharmaceutical, cosmetic, and nutraceutical companies.
Leading players are launching innovative technologies like Licaps®, which seal liquid organic ingredients in hard gelatin capsules, optimizing disintegration for fast release. These advancements have expanded the market's potential, attracting various industries and driving growth in the advanced empty capsules sector.
Principal Consultant
The market is projected to experience a steady rate of 11.3% CAGR during the period of 2018 to 2022, driven by the increasing demand for customized capsules and the rise in nutraceutical consumption.
Globally, there has been a significant increase in per capita healthcare spending, as evidenced by the World Health Organization's report stating that total healthcare spending in the United States reached US$ 3.6 trillion in 2018, growing by 4.6% compared to the previous year.
Furthermore, there is a growing demand for vegetarian-based capsules in the nutraceutical and pharmaceutical industries. Manufacturers are opting for these capsules to avoid manufacturing issues associated with gelatin alternatives. As a result, the market for vegetarian-based capsules is expected to witness substantial growth in the forecast period.
The demand for halal-certified products is also on the rise, particularly in countries with significant Muslim populations. This demand is driving pharmaceutical manufacturers to produce Halal-certified products, presenting opportunities for growth.
Key pharmaceutical companies are expanding their geographical presence to tap into this demand. For instance, Qualicaps® Europe, S.A.U. expanded its presence in the South Asia region in February 2020.
According to a report by Future Market Insights (FMI), the market is expected to expand at a 7.4% CAGR between 2023 and 2033, indicating promising growth prospects for the industry.
Europe expanded significantly, with a share of 67.5% in 2022, and is predicted to remain one of the most attractive markets during the forecast period. Russia is expected to grow during the forecast period, with a CAGR of 7.3% in 2023 to 2033.
The high demand for vitamin supplements is expected to drive the market in Russia. Vitamins are more stable and effective with the help of capsules. Empty capsule manufacturers are developing new, customized offerings to fulfill the requirements of vitamin efficacy and safety.
Demand in the United Kingdom market is expected to rise at 5.1% CAGR over the forecast period. The United Kingdom has witnessed a high level of healthcare spending in Europe. Due to rising research activities, the presence of several key players is creating attractive opportunities for this market in the country.
The United Kingdom healthcare system is backed by well-developed infrastructure and is largely supported by the government creating a conducive environment for long-term growth.
As one of the leading pharmaceutical manufacturers in the world, Germany held a prominent share of 21% in 2022 in the European market. It is projected to capture over 25.8% market share by 2033. In this competitive landscape, innovation emerges as the crucial factor for success.
Manufacturers in Germany are actively focusing on technological advancements, striving to provide unique and versatile offerings for pharmaceutical, nutraceutical, and cosmeceutical applications. Leading companies in the German market are dedicated to developing innovative products that cater to these industries.
For instance, ACG, a renowned supplier of integrated solutions to the global pharmaceutical and nutraceutical sector, introduced their new ACGcaps™ NTone and ACGcaps™ TSafe capsules for the nutraceutical market in March 2021. The ACGcaps™ TSafe range offers gelatin and HPMC capsules without titanium dioxide, presenting more choices to meet diverse customer needs.
By embracing innovation, German manufacturers gain a competitive edge, ensuring their products meet evolving market demands and exceed customer expectations. Continuous advancements in technology and product offerings propel the growth and success of companies operating in the German pharmaceutical market.
In 2021, India emerged as a significant player, accounting for over 60.7% of sales in the South Asian region. The Indian market is fueled by government initiatives aimed at providing quality and affordable healthcare, which serves as a catalyst for market development. During the forecast period, the Indian market is projected to have a CAGR of 7.9% by 2033.
Favorable government initiatives, such as the launch of National Health Insurance and relaxation in custom duties, are unlocking untapped markets in South Asia, contributing to steady regional growth. The demand for HPMC capsules remains high, further driving market dynamics with increased average selling prices (ASP).
Furthermore, in India, the transition from a volume-based to a value-based scheme is supported by various measures taken by governments and radiotherapy service providers. These measures include outcome-based pricing, benefit and risk sharing, price management, and competitive tendering. Such initiatives are reshaping the Indian healthcare landscape, fostering growth opportunities for pharmaceutical companies.
In summary, government initiatives, favorable market conditions, and a shift towards value-based schemes are driving sales in India's pharmaceutical market, while innovation remains the key to success in the highly competitive German pharmaceutical industry.
Australia is expected to develop at a CAGR of 12.1% over the forecast period. Cost-cutting initiatives to reduce the burden of healthcare, especially in developing economies, is creating opportunities. In 2022, the market in Australia was expanding at a share of 11.9%.
With the help of research and development, new drug delivery systems drive growth in the long-term. Reducing the manufacturing cost is also a key concern for the pharmaceutical industry, which potentially gives a boost to the market in Australia.
For instance, in 2020, Capsugel launched Coni-Snap®, hard gelatin, sprinkle capsules specifically designed to meet the needs of a rapidly growing population that have difficulty swallowing. It is also available in HPMC.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Based on product type, oral capsules are holding the lead, accounting for nearly 89.43% of the market in 2022. These capsules are produced for individual medications for a single patient, to provide specific doses and combinations to improve patient compliance. Hence, this is expected to increase demand.
Oral capsules are expected to remain the top choice for any patient, since they are easy to get, easy to swallow, are cost-effective, and prevent delayed released gastric degradation. The trend to use hard gelatin capsules to provide patients with therapy is expected to increase the use of empty capsules.
Vegetarian-based capsules are experiencing rapid growth, with a robust CAGR of 10.7% projected for the forecast period of 2023 to 2033. These capsules are being widely adopted by both the pharmaceutical and nutraceutical industries.
The increasing demand for vegetarian capsules is attributed to multiple factors. Firstly, there is a growing population of vegans and vegetarians who prefer plant-based alternatives. Additionally, concerns over allergies to animal-derived products have also fueled the demand for vegetarian-based capsules.
Manufacturers are leveraging cellulose as a substitute for animal sources, further driving the popularity of these capsules. This surge in demand presents a significant opportunity for manufacturers in the future.
Among advanced empty capsules, the size "0" segment dominated the market, with the leading revenue share of 19.3% in 2021. This size is highly favored due to the rising adoption of oral capsules.
Size "0" capsules have a capacity to hold up to 500 mg of drugs, which aligns with the volumes of many pharmaceutical dosages. Factors such as increased healthcare spending, improved patient compliance, and a high adoption rate of new drug delivery systems contribute to the growing interest in this market segment during the forecast period.
The pharmaceutical segment is projected to contribute the highest revenue share of 62.5% in 2022. Globally, the demand for advanced empty capsules in pharmaceutical applications is on the rise, as they are extensively used in the production of various pharmaceutical products.
The pharmaceutical industry is witnessing the emergence of new startups that are experiencing robust growth, supported by government initiatives and increased spending.
Government expenditure on healthcare is particularly high in wealthier countries, accounting for about 60% of total healthcare expenditure. Furthermore, global healthcare expenditure is anticipated to expand at a CAGR of 5% from 2019 to 2023. These factors collectively contribute to the strong sales of advanced empty capsules in the pharmaceutical sector.
The advanced empty capsule market is characterized by a competitive landscape, with key players vying for market share. Leading companies focus on research and development, technological advancements, and offering innovative capsule solutions to meet the diverse needs of the pharmaceutical, nutraceutical, and cosmeceutical industries.
Competition is driven by factors such as product quality, customization capabilities, pricing, and customer service. The market's competitive nature pushes companies to differentiate themselves and form strategic partnerships to expand their market presence and stay ahead in the dynamic market landscape.
Recent developments:
From 2018 to 2022, the market registered a CAGR of 11.3%.
The market is estimated to reach US$ 1,856.1 million by 2033.
Oral capsule hold high revenue potential.
Russia, the United Kingdom and Germany dominate the global market.
The market is forecast to register a CAGR of 7.4% through 2033.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product Type, 2023 to 2033
5.3.1. Oral Capsules
5.3.1.1. Dry formulation
5.3.1.2. Liquid formulation
5.3.2. Inhalation Capsules
5.3.2.1. Gelatin
5.3.2.2. HPMC
5.3.2.3. Starch
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Raw Material
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Raw Material, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Raw Material, 2023 to 2033
6.3.1. Animal Source
6.3.1.1. Contract Type-A (Pork Skin
6.3.1.2. Type-B Gelatin (Animal Bones & Calf Skin)
6.3.1.3. Fish Bone Gelatin
6.3.2. Vegetarian-based
6.3.2.1. Hydroxy Propyl Methyl Cellulose (HPMC)
6.3.2.2. Starch
6.3.2.3. Pullulan
6.4. Y-o-Y Growth Trend Analysis By Raw Material, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Raw Material, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Capsules Size
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Capsules Size, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Capsules Size, 2023 to 2033
7.3.1. Size "000" Capsules
7.3.2. Size "00" Capsules
7.3.3. Size "0" Capsules
7.3.4. Size "1" Capsules
7.3.5. Size "2" Capsules
7.3.6. Size "3" Capsules
7.3.7. Size "4" Capsules
7.3.8. Size "5" Capsules
7.4. Y-o-Y Growth Trend Analysis By Capsules Size, 2018 to 2022
7.5. Absolute $ Opportunity Analysis By Capsules Size, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2018 to 2022
8.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033
8.3.1. Pharmaceutical
8.3.2. Nutraceutical & Cosmetic
8.3.3. CROs
8.3.4. CMOs
8.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022
8.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
9.1. Introduction
9.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022
9.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. South Asia
9.3.5. East Asia
9.3.6. Oceania
9.3.7. MEA
9.4. Market Attractiveness Analysis By Region
10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. The USA
10.2.1.2. Canada
10.2.2. By Product Type
10.2.3. By Raw Material
10.2.4. By Capsules Size
10.2.5. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By Raw Material
10.3.4. By Capsules Size
10.3.5. By End User
10.4. Key Takeaways
11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Brazil
11.2.1.2. Mexico
11.2.1.3. Rest of Latin America
11.2.2. By Product Type
11.2.3. By Raw Material
11.2.4. By Capsules Size
11.2.5. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By Raw Material
11.3.4. By Capsules Size
11.3.5. By End User
11.4. Key Takeaways
12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Germany
12.2.1.2. United Kingdom
12.2.1.3. France
12.2.1.4. Spain
12.2.1.5. Italy
12.2.1.6. Rest of Europe
12.2.2. By Product Type
12.2.3. By Raw Material
12.2.4. By Capsules Size
12.2.5. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By Raw Material
12.3.4. By Capsules Size
12.3.5. By End User
12.4. Key Takeaways
13. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Malaysia
13.2.1.3. Singapore
13.2.1.4. Thailand
13.2.1.5. Rest of South Asia
13.2.2. By Product Type
13.2.3. By Raw Material
13.2.4. By Capsules Size
13.2.5. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.3.3. By Raw Material
13.3.4. By Capsules Size
13.3.5. By End User
13.4. Key Takeaways
14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Product Type
14.2.3. By Raw Material
14.2.4. By Capsules Size
14.2.5. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product Type
14.3.3. By Raw Material
14.3.4. By Capsules Size
14.3.5. By End User
14.4. Key Takeaways
15. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. Australia
15.2.1.2. New Zealand
15.2.2. By Product Type
15.2.3. By Raw Material
15.2.4. By Capsules Size
15.2.5. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product Type
15.3.3. By Raw Material
15.3.4. By Capsules Size
15.3.5. By End User
15.4. Key Takeaways
16. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
16.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
16.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
16.2.1. By Country
16.2.1.1. GCC Countries
16.2.1.2. South Africa
16.2.1.3. Israel
16.2.1.4. Rest of MEA
16.2.2. By Product Type
16.2.3. By Raw Material
16.2.4. By Capsules Size
16.2.5. By End User
16.3. Market Attractiveness Analysis
16.3.1. By Country
16.3.2. By Product Type
16.3.3. By Raw Material
16.3.4. By Capsules Size
16.3.5. By End User
16.4. Key Takeaways
17. Key Countries Market Analysis
17.1. USA
17.1.1. Pricing Analysis
17.1.2. Market Share Analysis, 2022
17.1.2.1. By Product Type
17.1.2.2. By Raw Material
17.1.2.3. By Capsules Size
17.1.2.4. By End User
17.2. Canada
17.2.1. Pricing Analysis
17.2.2. Market Share Analysis, 2022
17.2.2.1. By Product Type
17.2.2.2. By Raw Material
17.2.2.3. By Capsules Size
17.2.2.4. By End User
17.3. Brazil
17.3.1. Pricing Analysis
17.3.2. Market Share Analysis, 2022
17.3.2.1. By Product Type
17.3.2.2. By Raw Material
17.3.2.3. By Capsules Size
17.3.2.4. By End User
17.4. Mexico
17.4.1. Pricing Analysis
17.4.2. Market Share Analysis, 2022
17.4.2.1. By Product Type
17.4.2.2. By Raw Material
17.4.2.3. By Capsules Size
17.4.2.4. By End User
17.5. Germany
17.5.1. Pricing Analysis
17.5.2. Market Share Analysis, 2022
17.5.2.1. By Product Type
17.5.2.2. By Raw Material
17.5.2.3. By Capsules Size
17.5.2.4. By End User
17.6. United Kingdom
17.6.1. Pricing Analysis
17.6.2. Market Share Analysis, 2022
17.6.2.1. By Product Type
17.6.2.2. By Raw Material
17.6.2.3. By Capsules Size
17.6.2.4. By End User
17.7. France
17.7.1. Pricing Analysis
17.7.2. Market Share Analysis, 2022
17.7.2.1. By Product Type
17.7.2.2. By Raw Material
17.7.2.3. By Capsules Size
17.7.2.4. By End User
17.8. Spain
17.8.1. Pricing Analysis
17.8.2. Market Share Analysis, 2022
17.8.2.1. By Product Type
17.8.2.2. By Raw Material
17.8.2.3. By Capsules Size
17.8.2.4. By End User
17.9. Italy
17.9.1. Pricing Analysis
17.9.2. Market Share Analysis, 2022
17.9.2.1. By Product Type
17.9.2.2. By Raw Material
17.9.2.3. By Capsules Size
17.9.2.4. By End User
17.10. China
17.10.1. Pricing Analysis
17.10.2. Market Share Analysis, 2022
17.10.2.1. By Product Type
17.10.2.2. By Raw Material
17.10.2.3. By Capsules Size
17.10.2.4. By End User
17.11. Japan
17.11.1. Pricing Analysis
17.11.2. Market Share Analysis, 2022
17.11.2.1. By Product Type
17.11.2.2. By Raw Material
17.11.2.3. By Capsules Size
17.11.2.4. By End User
17.12. South Korea
17.12.1. Pricing Analysis
17.12.2. Market Share Analysis, 2022
17.12.2.1. By Product Type
17.12.2.2. By Raw Material
17.12.2.3. By Capsules Size
17.12.2.4. By End User
17.13. Singapore
17.13.1. Pricing Analysis
17.13.2. Market Share Analysis, 2022
17.13.2.1. By Product Type
17.13.2.2. By Raw Material
17.13.2.3. By Capsules Size
17.13.2.4. By End User
17.14. Thailand
17.14.1. Pricing Analysis
17.14.2. Market Share Analysis, 2022
17.14.2.1. By Product Type
17.14.2.2. By Raw Material
17.14.2.3. By Capsules Size
17.14.2.4. By End User
17.15. Indonesia
17.15.1. Pricing Analysis
17.15.2. Market Share Analysis, 2022
17.15.2.1. By Product Type
17.15.2.2. By Raw Material
17.15.2.3. By Capsules Size
17.15.2.4. By End User
17.16. Australia
17.16.1. Pricing Analysis
17.16.2. Market Share Analysis, 2022
17.16.2.1. By Product Type
17.16.2.2. By Raw Material
17.16.2.3. By Capsules Size
17.16.2.4. By End User
17.17. New Zealand
17.17.1. Pricing Analysis
17.17.2. Market Share Analysis, 2022
17.17.2.1. By Product Type
17.17.2.2. By Raw Material
17.17.2.3. By Capsules Size
17.17.2.4. By End User
17.18. GCC Countries
17.18.1. Pricing Analysis
17.18.2. Market Share Analysis, 2022
17.18.2.1. By Product Type
17.18.2.2. By Raw Material
17.18.2.3. By Capsules Size
17.18.2.4. By End User
17.19. South Africa
17.19.1. Pricing Analysis
17.19.2. Market Share Analysis, 2022
17.19.2.1. By Product Type
17.19.2.2. By Raw Material
17.19.2.3. By Capsules Size
17.19.2.4. By End User
17.20. Israel
17.20.1. Pricing Analysis
17.20.2. Market Share Analysis, 2022
17.20.2.1. By Product Type
17.20.2.2. By Raw Material
17.20.2.3. By Capsules Size
17.20.2.4. By End User
18. Market Structure Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Market Share Analysis of Top Players
18.3.1. By Regional
18.3.2. By Product Type
18.3.3. By Raw Material
18.3.4. By Capsules Size
18.3.5. By End User
19. Competition Analysis
19.1. Competition Deep Dive
19.1.1. Capsugel (Lonza)
19.1.1.1. Overview
19.1.1.2. Product Portfolio
19.1.1.3. Profitability by Market Segments
19.1.1.4. Sales Footprint
19.1.1.5. Strategy Overview
19.1.1.5.1. Marketing Strategy
19.1.1.5.2. Product Strategy
19.1.1.5.3. Channel Strategy
19.1.2. ACG Worldwide
19.1.2.1. Overview
19.1.2.2. Product Portfolio
19.1.2.3. Profitability by Market Segments
19.1.2.4. Sales Footprint
19.1.2.5. Strategy Overview
19.1.2.5.1. Marketing Strategy
19.1.2.5.2. Product Strategy
19.1.2.5.3. Channel Strategy
19.1.3. Medi-Caps Limited
19.1.3.1. Overview
19.1.3.2. Product Portfolio
19.1.3.3. Profitability by Market Segments
19.1.3.4. Sales Footprint
19.1.3.5. Strategy Overview
19.1.3.5.1. Marketing Strategy
19.1.3.5.2. Product Strategy
19.1.3.5.3. Channel Strategy
19.1.4. Sunil Healthcare Limited
19.1.4.1. Overview
19.1.4.2. Product Portfolio
19.1.4.3. Profitability by Market Segments
19.1.4.4. Sales Footprint
19.1.4.5. Strategy Overview
19.1.4.5.1. Marketing Strategy
19.1.4.5.2. Product Strategy
19.1.4.5.3. Channel Strategy
19.1.5. Roxlor LLC
19.1.5.1. Overview
19.1.5.2. Product Portfolio
19.1.5.3. Profitability by Market Segments
19.1.5.4. Sales Footprint
19.1.5.5. Strategy Overview
19.1.5.5.1. Marketing Strategy
19.1.5.5.2. Product Strategy
19.1.5.5.3. Channel Strategy
19.1.6. CapsCanada Corporation
19.1.6.1. Overview
19.1.6.2. Product Portfolio
19.1.6.3. Profitability by Market Segments
19.1.6.4. Sales Footprint
19.1.6.5. Strategy Overview
19.1.6.5.1. Marketing Strategy
19.1.6.5.2. Product Strategy
19.1.6.5.3. Channel Strategy
19.1.7. Suheung Co., Ltd.
19.1.7.1. Overview
19.1.7.2. Product Portfolio
19.1.7.3. Profitability by Market Segments
19.1.7.4. Sales Footprint
19.1.7.5. Strategy Overview
19.1.7.5.1. Marketing Strategy
19.1.7.5.2. Product Strategy
19.1.7.5.3. Channel Strategy
19.1.8. Bright Pharma Caps
19.1.8.1. Overview
19.1.8.2. Product Portfolio
19.1.8.3. Profitability by Market Segments
19.1.8.4. Sales Footprint
19.1.8.5. Strategy Overview
19.1.8.5.1. Marketing Strategy
19.1.8.5.2. Product Strategy
19.1.8.5.3. Channel Strategy
19.1.9. STERIS Plc
19.1.9.1. Overview
19.1.9.2. Product Portfolio
19.1.9.3. Profitability by Market Segments
19.1.9.4. Sales Footprint
19.1.9.5. Strategy Overview
19.1.9.5.1. Marketing Strategy
19.1.9.5.2. Product Strategy
19.1.9.5.3. Channel Strategy
19.1.10. Fuji Capsule Co. Ltd.
19.1.10.1. Overview
19.1.10.2. Product Portfolio
19.1.10.3. Profitability by Market Segments
19.1.10.4. Sales Footprint
19.1.10.5. Strategy Overview
19.1.10.5.1. Marketing Strategy
19.1.10.5.2. Product Strategy
19.1.10.5.3. Channel Strategy
19.1.11. QUALICAPS
19.1.11.1. Overview
19.1.11.2. Product Portfolio
19.1.11.3. Profitability by Market Segments
19.1.11.4. Sales Footprint
19.1.11.5. Strategy Overview
19.1.11.5.1. Marketing Strategy
19.1.11.5.2. Product Strategy
19.1.11.5.3. Channel Strategy
20. Assumptions & Acronyms Used
21. Research Methodology
Explore Healthcare Insights
View Reports
Advanced Empty Capsule Market
